[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"characteristics-disease\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:characteristics-disease":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100458093","augsburg-longitudinal-plasma-study-for-the-evaluation-of-liquid-biopsy-as-diagnostic-tool-100458093",false,"NCT05245136","Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.","Augsburg Longitudinal Plasma Study (ALPS) to Study Liquid Biopsy (LBx) as a Tool for Diagnostic Support, Assessment of Disease Progression, and Identification of Mutations During Disease Course in Patients With Solid Neoplasms Receiving Palliative Treatment","ALPS","Inclusion Criteria:\n\n* Written informed consent\n* Age ≥ 18 years\n* Histopathologically confirmed metastatic or locally advanced cancer\n* No curative treatment options, except for germ cell tumors\n* Written Agreement to be followed up at Augsburg University Medical Center\n* Signed written informed consent for the Biobank Augsburg (Biobank-A)\n* Willing to undergo treatment according to standard of care\n* Availability or anticipated availability of tumor tissue at time point of inclusion\n* Anticipated life expectancy of at least 3 months at time point of trial inclusion\n\nExclusion Criteria:\n\n* Psychological condition that would preclude informed consent\n* Additional tumor treatment between acquisition of tumor tissue and trial inclusion","ALL","18 Years",{"count":20,"type":21},3000,"ESTIMATED","OBSERVATIONAL","A prospective observational trial of patients with metastatic cancer of various entities which aims at both clarifying the significance of liquid biopsy and establishing a foundation for translational research.",[25,26,27],"Characteristics Disease","Metastatic Cancer","Solid Tumor","RECRUITING","2026-07-29",{"date":31,"type":32},"2026-07-30","ACTUAL",{"date":34,"type":32},"2021-03-29",{"date":36,"type":21},"2030-03",{"name":38,"class":39},"University Hospital Augsburg","OTHER"]